ImmunoPET: concept, design, and applications

W Wei, ZT Rosenkrans, J Liu, G Huang, QY Luo… - Chemical …, 2020 - ACS Publications
Immuno-positron emission tomography (immunoPET) is a paradigm-shifting molecular
imaging modality combining the superior targeting specificity of monoclonal antibody (mAb) …

State of the art in radiolabeling of antibodies with common and uncommon radiometals for preclinical and clinical immuno-PET

M Chomet, GAMS van Dongen… - Bioconjugate chemistry, 2021 - ACS Publications
Inert and stable radiolabeling of monoclonal antibodies (mAb), antibody fragments, or
antibody mimetics with radiometals is a prerequisite for immuno-PET. While radiolabeling is …

ImmunoPET: antibody-based PET imaging in solid tumors

R Manafi-Farid, B Ataeinia, S Ranjbar… - Frontiers in …, 2022 - frontiersin.org
Immuno-positron emission tomography (immunoPET) is a molecular imaging modality
combining the high sensitivity of PET with the specific targeting ability of monoclonal …

ImmunoPET imaging of multiple myeloma with [68Ga]Ga-NOTA-Nb1053

C Wang, Y Chen, YN Hou, Q Liu, D Zhang… - European Journal of …, 2021 - Springer
Purpose Multiple myeloma (MM) remains incurable and its diagnosis relies heavily on bone
marrow aspiration and biopsy. CD38 is a glycoprotein highly specific for MM. Antibody …

Evolving roles of CD38 metabolism in solid tumour microenvironment

L Gao, X Du, J Li, FXF Qin - British Journal of Cancer, 2023 - nature.com
Given that plenty of clinical findings and reviews have already explained in detail on the
progression of CD38 in multiple myeloma and haematological system tumours, here we no …

Theranostic application of 64Cu/177Lu-labeled anti-Trop2 monoclonal antibody in pancreatic cancer tumor models

C Li, J Liu, X Yang, Q Yang, W Huang, M Zhang… - European Journal of …, 2022 - Springer
Purpose Pancreatic cancer is a malignant tumor with a high degree of malignancy, strong
heterogeneity, and high lethality. Trop2 is a transmembrane glycoprotein associated with the …

Overcoming the resistance of hepatocellular carcinoma to PD-1/PD-L1 inhibitor and the resultant immunosuppression by CD38 siRNA-loaded extracellular vesicles

J Deng, H Ke - Oncoimmunology, 2023 - Taylor & Francis
Extracellular vesicles (EVs) are promising tools for drug delivery across different biological
barriers. Here, we evaluated the potential of EVs-mediated delivery of CD38 siRNA on the …

The circular life of human CD38: from basic science to clinics and back

AL Horenstein, AC Faini, F Morandi, C Bracci, F Lanza… - Molecules, 2020 - mdpi.com
Monoclonal antibodies (mAbs) were initially considered as a possible “magic bullet” for in
vivo elimination of tumor cells. mAbs represented the first step: however, as they were …

Advanced radionuclides in diagnosis and therapy for hepatocellular carcinoma

H Chen, M Teng, H Zhang, X Liang, H Cheng… - Chinese Chemical …, 2022 - Elsevier
Hepatocellular carcinoma (HCC) is the most common primary malignant tumor of the liver,
but early diagnosis and effective treatment are still difficult. With the development of …

64Cu radiolabeled nanomaterials for positron emission tomography (PET) imaging

X Chen, W Niu, Z Du, Y Zhang, D Su, X Gao - Chinese Chemical Letters, 2022 - Elsevier
The prevalence of positron emission tomography (PET) imaging has advanced biomedical
applications for its ultrahigh sensitivity, deep tissue penetration and quantitative visualization …